Exchange: NASDAQΒ·Updated 04:10 PM EST
LYEL logo

LYEL Lyell Immunopharma Inc

$13.80
$0.22
(1.62%)
Today
Closed $13.80
$0.00
(0.00%)
After Hours
Reported EarningsNov 4
Mkt Cap$333.87M
Vol171,086.00

About LYEL

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.
43

Bearish Sentiment

How do you feel about LYEL?

Quantumup
Baird reiterated $LYEL Outperform-$49 and said--Incrementally positive on external program update. [ $GILD ACLX IOVA LEGN NVS ALLO AUTL] Last Thursday, Kite/Gilead announced that the FDA placed a partial clinical hold on trials evaluating its autologous CD19/CD20 CAR-T therapy KITE-753 due to higher instances of Gr.3/4 ICANS. While Lyell's ronde-cel is also a dual CD19/CD20 CAR-T, we believe ronde-cel's differentiated design and prophylactic steroids should help insulate the program from these safety risks. Looking ahead, we await interim data from the pivotal PiNACLE study evaluating ronde-cel in 3L+ LBCL (likely at ASH, abstracts release November 4 at 9 a.m. ET), with PFS being the focus.
3
Rayvio_News_Filter
$LYEL πŸ₯ Lyell Immunopharma, Inc. announced updated clinical data from its PiNACLE pivotal trial in 3L+ R/R LBCL showing a 91% overall response rate and 77% complete response rate among 44 efficacy-evaluable patients, with pivotal data disclosure on track for mid-2027. Curated for market relevance
1
Rayvio_News_Filter
$LYEL πŸ₯ Lyell Immunopharma disclosed updated Ronde-cel clinical data in relapsed/refractory large B-cell lymphoma, reporting a 91% overall response rate and 77% complete response rate in 44 3L+ PiNACLE patients and a 95% overall response rate and 76% complete response rate in 37 2L Phase 1/2 patients. Selected from hundreds of headlines
1
Disrupter
$LYEL Volume is interestingly low which is bullish but no short attack yet to possibly ⛽️ the run
TA_Kongen
$LYEL Best in class data here. Unfortunately the sample size is smaller. Around 40. Compared to other competitors (400). When comparing BIC treatments.
LLYW
$LYEL not bad already up 35 mil on placement at 10.70 on 1 million $ worth of trading lol. That’s how Wall Street gets rich
focafoca99
$LYEL released details of an $80 million private placement to fund its CAR-T pipeline and extend cash runway into 2028.

Advertisement|Remove ads.